Clinical Trials

24 enrolled

Adenoma, Islet Cell, Pancreatic Neoplasms

NCT04924075 2026-05-11

MK-6482-015

322 enrolled 1 FDA

CNSEndocrine

von Hippel-Lindau Disease, Adenoma, Islet Cell, Paraganglioma, Pheochromocytoma

NCT07554560 2026-05-07

Nutrition Intervention for Pancreatic Cancer

18 enrolled

Adenoma, Islet Cell, Exocrine Pancreatic Insufficiency

NCT06943755 2026-04-17

STELLAR-311

Phase 2/3 Recruiting

440 enrolled

EndocrineNET

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT07165132 2026-04-13

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

EndocrineGastrointestinalNET

104 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT06141369 2026-04-09

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

EndocrineGastrointestinalNET

21 enrolled

Endocrine

Adenoma, Islet Cell, Adrenocortical Carcinoma, Carcinoma, Medullary

NCT05477576 2026-03-30

ACTION-1

Phase 3 Recruiting

338 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT05847855 2026-03-25

Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors

1,000 enrolled

Adenoma, Islet Cell

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

BreastCNSDermatologicEndocrineHead & NeckNETThoracic

18 enrolled

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

NCT06202066 2026-03-11

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

60 enrolled

Adenoma, Islet Cell

NCT00830557 2026-03-09

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

20,000 enrolled

Hereditary pancreatitis, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Pancreatitis, Somatostatinoma, Carcinoma, Islet Cell, Pancreatitis, Chronic

NCT07439757 2026-02-27

AI-Powered Precision Decision-Making for Pancreatic Diseases

2,000 enrolled

Pancreatic Intraductal Neoplasms, Adenoma, Islet Cell, Pancreatic Neoplasms, Pancreatitis, Pancreatitis, Chronic

NCT05746182 2026-01-26

PanNEN

300 enrolled

Adenoma, Islet Cell

NCT07273409 2026-01-22

PANTODON

200 enrolled

Adenoma, Islet Cell

NCT07328607 2026-01-21

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

90 enrolled

Adenoma, Islet Cell

NCT06663072 2026-01-09

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

25 enrolled

Adenoma, Islet Cell

NCT05040360 2025-12-15

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

141 enrolled

Adenoma, Islet Cell

NCT04520932 2025-05-25

RFANET

82 enrolled

Adenoma, Islet Cell

NCT06121622 2025-05-01

3DPanNET

70 enrolled

Adenoma, Islet Cell

NCT06592989 2025-01-10

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

20 enrolled

Adenoma, Islet Cell

NCT05037461 2024-12-18

PRIME

20 enrolled

Endocrine

Adenoma, Islet Cell, Multiple Endocrine Neoplasia Type 1

NCT06041009 2024-10-18

Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations

2,100 enrolled

Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Pancreatitis

NCT06523582 2024-07-26

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

CNSEndocrineGastrointestinalHead & NeckNETSarcoma

750 enrolled

Carney-Stratakis Syndrome, Carney Triad, Pituitary Adenoma, Familial Isolated, Colorectal Neoplasms, Hereditary Nonpolyposis, Hamartoma Syndrome, Multiple, von Hippel-Lindau Disease, Adenoma, Islet Cell, Neurofibromatosis 1, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Tuberous Sclerosis, Li-Fraumeni Syndrome, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Gastrointestinal Stromal Tumors, Hyperparathyroidism, Primary, Carney Complex

NCT05997056 2024-07-16

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

EndocrineGastrointestinalNET

21 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

NCT06472388 2024-06-25

EVENET